FLGT

Companies
NASDAQ
Fulgent Genetics Inc.
Health Care
Price Chart
Overview

About FLGT

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

Market Cap
$607.5M
Volume
7.8M
Avg. Volume
8.0M
P/E Ratio
-39.901962
Dividend Yield
0.00%
Employees
720.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Diagnostics & Research
Risk & Correlation Analysis
Market Correlation
0.73
Low Correlation
Volatility
High (0.43)
Relative to market

Macro Factor Sensitivities

Interest Rates
Medium Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for FLGT.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, FLGT shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$607.5M
Volume7.8M
P/E Ratio-39.90
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 2, 2025

PortfolioPilot Analysis

Get AI-powered insights on how FLGT fits into your investment strategy and portfolio diversification.

Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025